Tag Archives: FDA

Onco360 Selected as Pharmacy Partner for Tibsovo and ORGOVYX®

Onco360, the nation’s largest independent Oncology Pharmacy and clinical support services company, was recently selected to be the pharmacy partner for Tibsovo and ORGOVYX®

Nobelpharma America Selects AllianceRx Walgreens and Total Care Rx to Distribute Hyftor

Nobelpharma America Selects AllianceRx Walgreens and Total Care Rx to Distribute Hyftor

EVERSANA and Accord BioPharma Support Launch of CAMCEVI®

EVERSANA and Accord BioPharma announced a partnership to support the recent launch of CAMCEVI® (leuprolide) 42mg injection emulsion for the treatment of advanced prostate cancer in adults

Biologics by McKesson Selected to Provide VONJO and PYRUKYND

Biologics by McKesson continues to solidify its leadership position a provider for limited and exclusive drugs in the specialty pharmacy market

Biologics Selected by Agios Pharmaceuticals as Exclusive Distributor of PYRUKYND®

PYRUKYND prescriptions are processed exclusively through Biologics by McKesson to give patients a seamless experience

PANTHERx Rare Selected by Aadi Bioscience as Exclusive Distributor for FYARRO™

PANTHERx Rare announced that it has been selected by Aadi Bioscience (Aadi) as the exclusive U.S. pharmacy distribution partner for new drug FYARRO™ (sirolimus protein-bound particles for injectable suspension) (albumin-bound)

argenx SE Selects Soleo Health as a Limited Distribution Partner for VYVGART

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, recently announced it was selected as a limited distribution partner for VYVGART

Idorsia Ltd. Strengthens Commercialization Collaboration with Syneos Health

Idorsia Ltd. and Syneos Health® announced the extension of an existing collaboration to commercialize daridorexant, a novel dual orexin receptor antagonist for the treatment of insomnia across Europe and Canada